A tailored approach to fusion transcript identification increases diagnosis of rare inherited disease

• Published in: PloS one Vol. 14; no. 10; p. e0223337
• Main Authors: Oliver, Gavin R., Tang, Xiaojia, Schultz-Rogers, Laura E., Vidal-Folch, Noemi, Jenkinson, W. Garrett, Schwab, Tanya L., Gaonkar, Krutika, Cousin, Margot A., Nair, Asha, Basu, Shubham, Chanana, Pritha, Oglesbee, Devin, Klee, Eric W.
• Format: Journal Article
• Language: English
• Published: United States Public Library of Science 02.10.2019; Public Library of Science (PLoS)
• Subjects: Adolescent; Adult; Aged; Algorithms; Annotations; Biochemistry; Bioinformatics; Biology and life sciences; Cancer; Cancer research; Child; Child, Preschool; Criminal investigation; Diagnosis; Diagnostic systems; Female; Gene expression; Gene fusion; Gene sequencing; Genes; Genetic Association Studies - methods; Genetic Diseases, Inborn - diagnosis; Genetic Diseases, Inborn - genetics; Genetic disorders; Genetic engineering; Genetic Markers; Genetic Predisposition to Disease; Genetic screening; Genomes; Genomics; Health sciences; Hereditary diseases; Humans; Infant; Inheritance Patterns; Laboratories; Male; Medical diagnosis; Medical research; Medicine and Health Sciences; Middle Aged; Mutant Chimeric Proteins - genetics; Mutation; Nucleotide sequence; Pathology; Phenotype; Phenotypes; Precision medicine; Rare Diseases - diagnosis; Rare Diseases - genetics; Research and Analysis Methods; Ribonucleic acid; Risk factors; RNA; RNA sequencing; Splicing; Transcription; Transcription (Genetics); Tumors; Workflow; Workflow software; Young Adult; United States > US; Minnesota
• ISSN: 1932-6203; 1932-6203
• DOI: 10.1371/journal.pone.0223337

RNA sequencing has been proposed as a means of increasing diagnostic rates in studies of undiagnosed rare inherited disease. Recent studies have reported diagnostic improvements in the range of 7.5-35% by profiling splicing, gene expression quantification and allele specific expression. To-date however, no study has systematically assessed the presence of gene-fusion transcripts in cases of germline disease. Fusion transcripts are routinely identified in cancer studies and are increasingly recognized as having diagnostic, prognostic or therapeutic relevance. Isolated reports exist of fusion transcripts being detected in cases of developmental and neurological phenotypes, and thus, systematic application of fusion detection to germline conditions may further increase diagnostic rates. However, current fusion detection methods are unsuited to the investigation of germline disease due to performance biases arising from their development using tumor, cell-line or in-silico data. We describe a tailored approach to fusion candidate identification and prioritization in a cohort of 47 undiagnosed, suspected inherited disease patients. We modify an existing fusion transcript detection algorithm by eliminating its cell line-derived filtering steps, and instead, prioritize candidates using a custom workflow that integrates genomic and transcriptomic sequence alignment, biological and technical annotations, customized categorization logic, and phenotypic prioritization. We demonstrate that our approach to fusion transcript identification and prioritization detects genuine fusion events excluded by standard analyses and efficiently removes phenotypically unimportant candidates and false positive events, resulting in a reduced candidate list enriched for events with potential phenotypic relevance. We describe the successful genetic resolution of two previously undiagnosed disease cases through the detection of pathogenic fusion transcripts. Furthermore, we report the experimental validation of five additional cases of fusion transcripts with potential phenotypic relevance. The approach we describe can be implemented to enable the detection of phenotypically relevant fusion transcripts in studies of rare inherited disease. Fusion transcript detection has the potential to increase diagnostic rates in rare inherited disease and should be included in RNA-based analytical pipelines aimed at genetic diagnosis.